Study Site 228 — Louisville, Kentucky

Study Site 228 is a clinical research site located in Louisville, Kentucky, United States 40202.

Crixeo Health Trust Score: 60/100 (FAIR). This profile has not yet been claimed by the site owner.

Study Site 228 has participated in 3 clinical trials.

Therapeutic areas: Pruritus, Prurigo Nodularis, Atopic Dermatitis.

Sponsors: Vyne Therapeutics Inc..

Sponsor Feasibility Report

Trust Score: 60/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Study Site 228?

Study Site 228 has a Crixeo Trust Score of 60/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Study Site 228 conducted?

Study Site 228 has 3 clinical trials on record. Their work covers Pruritus, Prurigo Nodularis, Atopic Dermatitis.

Is Study Site 228 accredited by Crixeo Health?

Study Site 228 has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Study Site 228?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.